INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Free cash flow 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$31.1MFY2025 · since FY2016: $69.1M → -$31.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.1M | -224.4% |
| FY2024 | $25.0M | -65.8% |
| FY2023 | $73.1M | -67.1% |
| FY2022 | $222.1M | -16.0% |
| FY2021 | $264.4M | +60.3% |
| FY2020 | $164.9M | +1.9% |
| FY2019 | $161.9M | +32.8% |
| FY2018 | $121.9M | +71.7% |
| FY2017 | $71.0M | +2.8% |
| FY2016 | $69.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IART financial trends
IART RevenueIART Net incomeIART Net marginIART Gross profitIART Gross marginIART Operating incomeIART Operating marginIART Operating cash flowIART Capital expendituresIART Return on equityIART Stock buybacksIART Dividends paidIART Total assetsIART Total liabilitiesIART Shareholders’ equityIART overview →